Details of the Drug Reposition

General Information of This Drug (ID: DMSEXNP)

Drug Name
Sipuleucel-T   DMSEXNP
Synonyms APC8015

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Prostate cancer DISF190Y 2C82.0 Approved [1]
------------------------------------------------------------------------------------
1 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Human immunodeficiency virus-1 infection DISRZ2R6 1C62 Phase 3 [2]
------------------------------------------------------------------------------------

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services
2 ClinicalTrials.gov (NCT01133704) Immunotherapy With APC8015 (Sipuleucel-T, Provenge) for Asymptomatic, Metastatic, Hormone-Refractory Prostate Cancer. U.S. National Institutes of Health.